Can a simple supplement speed up bone healing?
NCT ID NCT07299851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 12-week course of a cetylated fatty acid supplement can improve bone healing after surgery for a broken femur or tibia. One hundred adults will receive either the supplement or a placebo, and healing will be tracked with X-rays and pain scores. The goal is to see if the supplement helps bones mend faster and reduces discomfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cetylated fatty acids (dietary supplement)
- What this could lead to
- If it works, this supplement could help bones heal faster and reduce pain after a leg fracture.
- What could go wrong
- This is an early-stage trial with only 100 participants, so results may not apply to everyone. The supplement may show no benefit over placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Between 18 and 85 years old * Presence of simple closed unifocal fracture (transverse, oblique, spiral, butterfly-shaped) in a long bone which need a standard of care surgical stabilization * Presence of diaphyseal fracture of lower limb (femur or tibia, Subtrochanteric fracture are also allowed) * Presence intramedullary nail * Weight bearing as tolerated after surgery * Having signed an informed consent, understand study procedures and ability to follow them * Agreed to stop vitamin D intake for participants who take prophylactic Vitamin D Exclusion Criteria: * Treatment with vitamin D for medical purpose (Non-union, osteoporosis…) * BMI \> 30 * Open fracture * Intra articular fracture * Metaphyseal fracture * Polytrauma patient (injury severity score: ISS \>= 16) * More than one lower limb long bone fracture * Bridging plate * Fracture treated conservatively with plaster * Presence of active infection (body temperature ≥ 38°C or other symptoms) * Any sign of severe vascular compromise across the fracture site (such as compartment syndrome, presence of serious vascular damage, etc.) * Pathological fracture or diseases with a risk of recurrent falling (e.g. Parkinson's disease/syndrome, Hemiplegia after stroke, symptomatic stenosis of the spinal canal, polyneuropathy, epilepsy, recurring vertigo, recurring syncope) * Participants with known bone disease which would negatively impact on the bone healing process * Participants currently being treated with radiation, chemotherapy, immunosuppression, or steroid therapy * Diabetic participants * Daily smoker participants (cigarette or vaping containing nicotine) * Participants under cortisone intake * Participants under rheumatic medications intake * Allergy or adverse effect of food supplement composition * Unwilling or unable to take study medication * Chronic drug or alcohol abuse * Pregnant or breastfeeding at the time of enrolment * Any other investigational treatment or food supplement within 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Femur fracture are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
6 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
AZ Monica
RECRUITINGDeurne, Antwerp, 2100, Belgium
-
Algemeen Ziekenhuis Herentals
RECRUITINGHerentals, Antwerp, 2200, Belgium
-
Hôpital Erasme - Cliniques Universitaires de Bruxelles
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
-
Universitair Ziekenhuis Brussel
RECRUITINGBrussels, Brussels Capital, 1090, Belgium
-
Universitair Ziekenhuis Gent
RECRUITINGGhent, Flanders, 9000, Belgium
-
Ziekenhuis Oost-Limburg
RECRUITINGGenk, Limburg, 3600, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple hole prevent dangerous emboli during bone surgery?
- Can robots perfectly align broken femurs?
- Can a nerve block beat painkillers for Broken-Bone positioning?
- One day of antibiotics may be enough after bone surgery
- New bone graft shows promise for healing leg breaks
- New anesthesia drug may reduce Post-Surgery confusion in seniors